Molecular radiotherapy (MRT) has demonstrated unique therapeutic advantages in the
treatment of an increasing number of cancers. As with other treatment modalities, there is related …

In this review we give an overview of current knowledge of 68 Ga-labeled pharmaceuticals,
with focus on imaging receptor-mediated processes. A major advantage of a 68 Ge/ 68 Ga …

Peptide receptor radionuclide therapy (PRRT) has been shown to be an effective treatment
for neuroendocrine tumors (NETs) if curative surgery is not an option. A majority of NETs …

The somatostatin analogue [DOTA 0 ,Tyr 3 ]octreotate has a nine-fold higher affinity for the
somatostatin receptor subtype 2 as compared with [DOTA 0 ,Tyr 3 ]octreotide. Also, labelled …

Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and can
be identified by PSMA-ligand imaging, which has already become clinically accepted in …

… Louis, MO, USA) and HR Maecke (Basel, Switzerland), and were dissolved in 0.01 M acetic
… M. The peptide and the radioactivity were mixed with 1.25 M Na-acetate. pH was measured …

Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma
(ICC)) are among the most frequent cancers worldwide. However, only 10–20% of …

… be performed using the equation above, assuming m tumour = 0 (non-compartmental MIRD
… , the two above equations should be applied replacing m liver with m lobe or m segment . …

The accuracy of absorbed dose calculations in personalized internal radionuclide therapy is
directly related to the accuracy of the activity (or activity concentration) estimates obtained at …

The purpose of the EANM Dosimetry Committee is to provide recommendations and guidance
to scientists and clinicians on patient-specific dosimetry. Radiopharmaceuticals labelled …